ArticleJournal of cardiovascular translational research2025

Correction: The SGLT2 Inhibitor Canagliflozin Reduces Atherosclerosis by Enhancing Macrophage Autophagy.

Hongping Chen et al.PubMed ↗Publisher ↗

No numbers read from the abstract.